Market Overview:
The global peripheral stent systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of peripheral artery diseases (PAD) and rising demand for minimally invasive procedures. Based on type, the global peripheral stent systems market is segmented into nitinol, cobalt-chromium, and other types. Nitinol-based stents are expected to dominate the market during the forecast period owing to their superior properties such as biocompatibility and radiopacity. Based on application, hospitals are expected to account for the largest share of the global peripheral stent systems market in 2018 followed by clinics and others. Geographically, North America is estimated to account for the largest share of the global peripheral stent systems market in 2018 followed by Europe and Asia Pacific.
Product Definition:
A peripheral stent system is a device used to place and hold a stent in position within a blood vessel. The importance of peripheral stent systems is that they can help keep blood vessels open, which can improve blood flow and help reduce the risk of heart attack or stroke.
Nitinol:
Nitinol, also known as silicon-based polymer or silicones is a synthetic material that was first developed in 1960. Nitinol has the ability to form flexible and rigid structures when exposed to heat, light, or chemicals. It can be used as an implantable device (stent) for supporting blood vessels (arteries/venules), helping them recover their normal function by reducing inflammation & scarring and increasing flow of blood through the vessel walls.
Cobalt-Chromium:
Cobalt-Chromium is a metal alloy of 60% cobalt and 40% chrome. It has high corrosion resistance, which makes it suitable for manufacturing peripheral stents. The product also exhibits excellent fatigue resistance property, which increases its application in the medical industry.
Application Insights:
Based on application, the global peripheral stent systems market is segmented into hospitals, clinics and other medical facilities, and others. The hospitals segment dominated the overall market in terms of revenue in 2017. This high share is attributable to factors such as a high prevalence of cardiovascular diseases that require hospitalization for treatment along with a large number of surgeries every year. In addition, increasing awareness about these devices among healthcare professionals will boost growth over the forecast period.
The clinics and other medical facilities segment is expected to grow at a lucrative rate during the forecast period owing to an increase in patients suffering from various types of heart conditions requiring stenting procedures for recovery.
Regional Analysis:
North America dominated the global peripheral stent systems market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies and increasing prevalence of cardiovascular diseases are some factors responsible for its large share. In addition, growing number of clinical studies regarding new peripheral stent system devices is expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population base and improving economic conditions in emerging countries such as China and India.
Growth Factors:
- Increasing incidence of peripheral artery diseases (PAD) due to growing aging population and rising prevalence of risk factors such as obesity, smoking, and diabetes.
- Growing demand for minimally invasive procedures for the treatment of PAD.
- Technological advancements in peripheral stent systems that offer enhanced safety and efficacy profiles over traditional open surgical procedures.
- Rising healthcare expenditure by governments and private players to support the growth of the peripheral stent systems market worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Peripheral Stent Systems Market Research Report
By Type
Nitinol, Cobalt-Chromium, Other
By Application
Hospitals, Clinics, Others
By Companies
Perouse Medical, Bentley InnoMed, eucatech, Cook, BIOTRONIK, Terumo Medical, Bard Medical, Medtronic, Meril Life Sciences, Alvimedica, Balton, iVascular
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Peripheral Stent Systems Market Report Segments:
The global Peripheral Stent Systems market is segmented on the basis of:
Types
Nitinol, Cobalt-Chromium, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Perouse Medical
- Bentley InnoMed
- eucatech
- Cook
- BIOTRONIK
- Terumo Medical
- Bard Medical
- Medtronic
- Meril Life Sciences
- Alvimedica
- Balton
- iVascular
Highlights of The Peripheral Stent Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nitinol
- Cobalt-Chromium
- Other
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peripheral Stent Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peripheral Stent Systems are a type of medical device that help to support and maintain the patency of an artery. When an artery is blocked, it can cause significant pain and damage to the surrounding tissues. Peripheral Stent Systems are inserted into the arteries near their obstruction, and help to keep them open so that blood flow can continue unimpeded.
Some of the major players in the peripheral stent systems market are Perouse Medical, Bentley InnoMed, eucatech, Cook, BIOTRONIK, Terumo Medical, Bard Medical, Medtronic, Meril Life Sciences, Alvimedica, Balton, iVascular.
The peripheral stent systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peripheral Stent Systems Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Peripheral Stent Systems Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Peripheral Stent Systems Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Peripheral Stent Systems Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Peripheral Stent Systems Market Size & Forecast, 2020-2028 4.5.1 Peripheral Stent Systems Market Size and Y-o-Y Growth 4.5.2 Peripheral Stent Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nitinol
5.2.2 Cobalt-Chromium
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peripheral Stent Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peripheral Stent Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nitinol
9.6.2 Cobalt-Chromium
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nitinol
10.6.2 Cobalt-Chromium
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nitinol
11.6.2 Cobalt-Chromium
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nitinol
12.6.2 Cobalt-Chromium
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nitinol
13.6.2 Cobalt-Chromium
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peripheral Stent Systems Market: Competitive Dashboard
14.2 Global Peripheral Stent Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Perouse Medical
14.3.2 Bentley InnoMed
14.3.3 eucatech
14.3.4 Cook
14.3.5 BIOTRONIK
14.3.6 Terumo Medical
14.3.7 Bard Medical
14.3.8 Medtronic
14.3.9 Meril Life Sciences
14.3.10 Alvimedica
14.3.11 Balton
14.3.12 iVascular